PET-CT vs PET-MRI: — Is the Newer Machine Better?

Both scans use the same PET technology to show metabolic activity in the body. The difference is what sits alongside it: PET-CT pairs PET with a CT scan, which uses X-rays to image anatomy, while PET-MRI pairs PET with MRI, which uses magnetic fields and gives sharper detail in soft tissue such as the brain, liver and pelvis. PET-MRI also delivers a lower radiation dose because the MRI component adds no ionising radiation. The trade-off is that it takes longer, is available at very few centres in India, and the evidence base for most cancer indications is still developing compared to PET-CT.

PET-MRI is not available at CION centres. CION uses PET-CT, coordinated through partner imaging centres in Telangana and Andhra Pradesh. PET-MRI is available at very few sites in India overall — mainly selected large academic or private hospitals in a handful of major cities. For the cancer types most commonly managed at CION, PET-CT is the clinically appropriate and guideline-recommended scan.

It depends on the cancer type and the clinical question your oncologist is trying to answer. For cancers in or near the liver, certain brain tumours, prostate cancer and rectal cancer, MRI provides better soft-tissue detail and PET-MRI may add genuine value. For most other cancer types — including lung, breast, lymphoma and most head and neck cancers — NCCN, ASCO and ESMO guidelines specify PET-CT as the standard, and there is no established evidence that PET-MRI improves clinical outcomes in those situations. Being recommended PET-CT for most cancers is not a compromise.

Almost certainly because PET-CT is the appropriate scan for your cancer type and the question your team is trying to answer. For the majority of cancer indications, international guidelines recommend PET-CT, not PET-MRI. Availability also plays a role — PET-MRI is not accessible at most centres — but even where it is available, most oncologists would still choose PET-CT for most patients because the evidence supports it. If you want to understand the reasoning, ask your team directly: they should be able to tell you what information they are looking for and why PET-CT answers it.

PET-CT involves a radiation dose from both the radioactive tracer and the CT component. Your oncologist and radiology team weigh this against the clinical benefit before recommending any scan — and for a cancer investigation, that benefit is almost always clearly greater. If repeated scanning is needed over months or years, cumulative radiation dose is something your team will factor in, and it is a reasonable question to raise. PET-MRI delivers a lower dose, but it is only a practical alternative in specific situations and at the very few centres that have the machine.

Only if your oncologist has specifically said it would change your treatment plan. For most patients, the scan result would be the same whether you had PET-CT locally or PET-MRI elsewhere — and the delay, cost and stress of travel are real. Ask at your next appointment: 'Is there anything MRI would show that CT cannot for my cancer?' If the answer is no, your local PET-CT is the right choice. If the answer is yes, your team will refer you appropriately rather than leaving you to arrange it yourself.